Authors: Edith Dieleman1, Lisa van der Woude2,3, Ernest Vonk4, Liselotte van Bockel5, Ida Coremans6, Corine van Es7, Katrien de Jaeger8, Hans Peter Knol9, Willemijn Kolff1, Frederike Koppe10, Jacqueline Pomp11, Bart Reymen12, Dominic Schinagl13, Femke Spoelstra14, Caroline Tissing-Tan15, Fred Ubbels16, Noelle van der Voort van Zyp17, Antoinet van der Wel18, Robin Wijsman16, M.F. Dielwart19, Erwin Wiegman20, Jose Belderbos21
1Amsterdam UMC location AMC, Radiation Oncology, Amsterdam, The Netherlands; 2RadboudUMC, Cardiothoracic surgery, Nijmegen, The Netherlands; 3Dutch Institute for Clinical Auditing,, -, Leiden, The Netherlands; 4Radiotherapie groep, Radiation Oncology, Deventer, The Netherlands; 5Haga ziekenhuis, Radiation Oncology, Den Haag, The Netherlands; 6LUMC, Radition Oncology, Leiden, The Netherlands; 7UMCU, Radiation Oncology, Utrecht, The Netherlands; 8Catharina Ziekenhuis, Radiation Oncology, Eindhoven, The Netherlands; 9Noordwest Ziekenhuis groep, Radiation Oncology, Alkmaar, The Netherlands; 10Instituut Verbeeten, Radiation Oncology, Tilburg, The Netherlands; 11Medisch Spectrum Twente, Radiation Oncology, Enschede, The Netherlands; 12Maastro, Radiation Oncology, Maastricht, The Netherlands; 13RadboudUMC, Radiation Oncology, Nijmegen, The Netherlands; 14Amsterdam UMC location VUMC, Radiation Oncology, Amsterdam, The Netherlands; 15Radiotherapie groep, Radiation Oncology, Arnhem, The Netherlands; 16UMCG, Radiation Oncology, Groningen, The Netherlands; 17MC Haaglanden, Radiation oncology, Den Haag, The Netherlands; 18Radiotherapeutisch Instituut Friesland, Radiation Oncology, Leeuwarden, The Netherlands; 19ZRTI, Radiation Oncology, Vlissingen, The Netherlands; 20Isala, Radiation Oncology, Zwolle, The Netherlands; 21Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands
Show Affiliations
Hide Affiliations